Tumor necrosis factor receptor-associated periodic syndrome: Difference between revisions
From IDWiki
mNo edit summary |
mNo edit summary |
||
Line 10: | Line 10: | ||
* Also: |
* Also: |
||
** Myalgias and limb pain, sometimes migratory (59 to 85%) |
** Myalgias and limb pain, sometimes migratory (59 to 85%) |
||
** Abdominal symptoms (36 to 74%), including pain and vomiting (18%) |
** Abdominal symptoms (36 to 74%), including pain and [[vomiting]] (18%) |
||
** Rash (55 to 63%), which is single or multiple erythematous patches that may spread downward |
** [[Rash]] (55 to 63%), which is single or multiple erythematous patches that may spread downward |
||
** Lymphadenopathy (25%) |
** [[Lymphadenopathy]] (25%) |
||
** Headache (20 to 25%) |
** [[Headache]] (20 to 25%) |
||
** Chest pain (14 to 25%) |
** Chest pain (14 to 25%) |
||
** Conjunctivitis (18 to 20%) |
** [[Conjunctivitis]] (18 to 20%) |
||
** Periorbital edema (9 to 20%) |
** Periorbital edema (9 to 20%) |
||
** Pharyngitis, with or without aphthae (9 to 18%) |
** [[Pharyngitis]], with or without aphthae (9 to 18%) |
||
** Monoarticular arthritis (13%) |
** [[Monoarticular arthritis]] (13%) |
||
** Hepatomegaly and/or splenomegaly (5 to 10%) |
** [[Hepatomegaly]] and/or [[splenomegaly]] (5 to 10%) |
||
** Occasionally, recurrent [[pericarditis]] |
** Occasionally, recurrent [[pericarditis]] |
||
** Secondary AA amyloidosis (10 to 15%) |
** Secondary AA [[amyloidosis]] (10 to 15%) |
||
==Diagnosis== |
==Diagnosis== |
||
* Presence of a confirmatory TNFRSF1A genotype |
* Presence of a confirmatory TNFRSF1A genotype and at least 1 among the following: |
||
** Duration of episodes ≥7 days |
** Duration of episodes ≥7 days |
||
** Myalgia |
** [[Myalgia]] |
||
** Migratory rash |
** Migratory rash |
||
** Periorbital |
** Periorbital edema |
||
** Relatives affected |
** Relatives affected |
||
* OR |
* OR |
||
* Presence of a not confirmatory TNFRSF1A genotype |
* Presence of a not confirmatory TNFRSF1A genotype and at least 2 among the following: |
||
** Duration of episodes ≥7 days |
** Duration of episodes ≥7 days |
||
** Myalgia |
** [[Myalgia]] |
||
** Migratory rash |
** Migratory rash |
||
** Periorbital |
** Periorbital edema |
||
** Relatives affected |
** Relatives affected |
||
[[Category:Periodic fever syndromes]] |
[[Category:Periodic fever syndromes]] |
Latest revision as of 19:58, 12 July 2023
Background
- A periodic fever syndrome caused by autoimmunity
- Autosomal dominant with incomplete penetrance
- Rare, described in all ethnic groups
- Usually presents in childhood, though 10% of cases are in those over age 30 years
Clinical Manifestations
- Fever over 38 degrees over months to years in the absence of infection
- Typically occur every five to six weeks, and last five days to 2 weeks or longer
- Also:
- Myalgias and limb pain, sometimes migratory (59 to 85%)
- Abdominal symptoms (36 to 74%), including pain and vomiting (18%)
- Rash (55 to 63%), which is single or multiple erythematous patches that may spread downward
- Lymphadenopathy (25%)
- Headache (20 to 25%)
- Chest pain (14 to 25%)
- Conjunctivitis (18 to 20%)
- Periorbital edema (9 to 20%)
- Pharyngitis, with or without aphthae (9 to 18%)
- Monoarticular arthritis (13%)
- Hepatomegaly and/or splenomegaly (5 to 10%)
- Occasionally, recurrent pericarditis
- Secondary AA amyloidosis (10 to 15%)
Diagnosis
- Presence of a confirmatory TNFRSF1A genotype and at least 1 among the following:
- Duration of episodes ≥7 days
- Myalgia
- Migratory rash
- Periorbital edema
- Relatives affected
- OR
- Presence of a not confirmatory TNFRSF1A genotype and at least 2 among the following:
- Duration of episodes ≥7 days
- Myalgia
- Migratory rash
- Periorbital edema
- Relatives affected